Oncology

Chapters

Transcript

Video

Austin Kim, MD discusses phase I/II study

Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)

Related Presenters

Austin Kim, MD.

Austin Kim, MD

Medical Oncology

View full profile

ADVERTISEMENT

Related Videos

Reid W. Merryman, MD discusses results of a multicenter phase II trial Video

Reid W. Merryman, MD discusses results of a multicenter phase II trial

Jacqueline Garcia, MD discussed results from the Phase # VERONA study Video

Jacqueline Garcia, MD discussed results from the Phase # VERONA study

Jennifer Brown, MD, PhD discusses results form the ALPINE trial Video

Jennifer Brown, MD, PhD discusses results form the ALPINE trial

Omar Nadeem, MD discusses results of the Phase II d-PRISM study Video

Omar Nadeem, MD discusses results of the Phase II d-PRISM study

Jorge J. Castillo, MD discusses results from a multicenter phase 2 Study Video

Jorge J. Castillo, MD discusses results from a multicenter phase 2 Study

Marlise Luskin, MD, MSCE discusses results of a phase 1 trial Video

Marlise Luskin, MD, MSCE discusses results of a phase 1 trial